DSM Company Facts and Shareholder Insights

Author

Reads 2K

Brown Concrete Building
Credit: pexels.com, Brown Concrete Building

DSM is a global company with a rich history dating back to 1902.

The company was founded by Gerben Sonneveld and Jurriaan van Meeteren in the Netherlands.

DSM has grown significantly over the years, with a presence in over 90 countries worldwide.

Today, DSM is a multinational company with a diverse portfolio of businesses, including nutrition, health, and sustainable living.

Financial Performance

DSM's financial performance is a key aspect of its overall health and success. The company's trailing total returns as of 10/2/2025 stand at a significant level, which may include dividends or other distributions.

The company's balance sheet is also noteworthy, with a total cash of $2.86B as of the most recent quarter. This is a substantial amount of liquidity that can be used to invest in the business or return to shareholders.

A closer look at the profitability metrics reveals some interesting insights. The profit margin stands at 5.52%, which indicates that DSM is able to maintain a healthy level of profitability despite the challenges in its industry. Return on assets (ROA) and return on equity (ROE) are also noteworthy, standing at 2.18% and 3.52% respectively.

Readers also liked: Retained Cash Flow / Net Debt

Credit: youtube.com, DSM sees 'pretty solid financial results for what was a challenging year,' co-CEO says

Here's a summary of DSM's key financial metrics:

DSM's revenue stands at $13.01B as of the most recent quarter, indicating a significant level of business activity. Net income available to common shareholders is $718M, which is a substantial amount of profit.

Investments and Acquisitions

DSM has been actively expanding its portfolio through strategic acquisitions. In 1998, the company acquired Gist-brocades, a business that specialized in food ingredients, pharmaceuticals, and yeast- and enzyme-based production process technology.

DSM's acquisition spree continued in 2000 with the purchase of Catalytica Pharmaceuticals, a company that focused on pharmaceutical intermediates. This move marked a significant step in DSM's growth as a global player in the pharmaceutical industry.

In 2003, DSM acquired Roche's vitamin division, further solidifying its position in the vitamin and nutritional supplements market. The acquisition of NeoResins in 2005 added water-based coating resins to DSM's product portfolio.

In 2011, DSM made two significant acquisitions: Martek, which specialized in nutritional products derived from microalgae and fermentation technology, and Vitatene, which produced natural carotenoids derived from the fermentation of Blakeslea trispora fungus.

Credit: youtube.com, Progress Tour – Episode 5: Acquisitions

Here are some of DSM's notable acquisitions:

  • 1998: Gist-brocades (food ingredients, pharmaceuticals, yeast- and enzyme-based production process technology)
  • 2000: Catalytica Pharmaceuticals (pharmaceutical intermediates)
  • 2003: Roche's vitamin division
  • 2005: NeoResins (water-based coating resins)
  • 2011: Martek (nutritional products derived from microalgae and fermentation technology)
  • 2011: Vitatene (natural carotenoids derived from fermentation of Blakeslea trispora fungus)
  • 2012: Verenium's food enzymes and oilseed processing business
  • 2012: Kensey Nash (biomedical regenerative medicine)
  • 2012: Ocean Nutrition Canada (fish-oil derived nutritional products)
  • 2012: Cargill's cultures and enzymes business
  • 2012: Fortitech (customized nutrient premixes)
  • 2013: Unitech (micronutrient premixes and macronutrient blends)
  • 2013: Andre Pectin (food hydrocolloids)
  • 2013: Tortuga (nutritional supplements for pasture raised cattle)
  • 2015: Åland (vitamin C)
  • 2015: Cubic Tech (high-performance, ultra-lightweight, flexible laminates and fabrics)
  • 2020: Erber Group – Biomin and Romer Labs (mycotoxin and allergen tests in food)
  • 2020: Glycom (human milk oligosaccharides, infant formula supplement)
  • 2021: Amyris Flavor & Fragrance business

In addition to these acquisitions, DSM has also made strategic investments in various companies. In 2023, DSM invested in Nutrileads, a company that specializes in nutritional ingredients.

Partnerships and Funding

DSM has been actively forming partnerships with various companies to further its business goals. These partnerships have been created with the ultimate goal of DSM exiting the businesses concerned.

In 2009, DSM signed contracts with NCPC to establish nutrition and anti-infectives joint ventures in China. This move marked the beginning of DSM's expansion into new markets.

DSM's joint ventures have been quite successful, with notable partnerships including DSM Sinochem Pharmaceuticals, a joint venture with the Sinochem Group established in 2011. This company is a manufacturer of generic anti-infective molecules.

In 2015, DSM formed another joint venture, ChemicaInvest, with CVC Capital Partners. This joint venture consists of three business units: Aliancys, AnQore, and Fibrant.

Credit: youtube.com, 'A merger of equals': Firmenich CEO Ghostine on DSM deal

DSM has also applied IFRS 11 to its associates and joint ventures since 2013, ensuring transparency and accountability in its business dealings.

Here are some key details about DSM's partnerships:

  • 2009: DSM and NCPC sign contracts to establish nutrition and anti-infectives joint ventures in China
  • 2011: DSM Sinochem Pharmaceuticals, joint venture (DSM 50%) with the Sinochem Group
  • 2015: ChemicaInvest, joint venture (DSM 35%) with CVC Capital Partners

Partnerships

DSM has been actively forming partnerships with a view to eventually exiting the businesses concerned.

In 2009, DSM signed contracts with NCPC to establish joint ventures in China for nutrition and anti-infectives.

These partnerships have been a key strategy for DSM, allowing the company to expand its reach and capabilities.

DSM Sinochem Pharmaceuticals, a joint venture with the Sinochem Group, was established in 2011.

It's a manufacturer of generic anti-infective molecules.

DSM holds a 50% stake in the joint venture.

ChemicaInvest, a joint venture with CVC Capital Partners, was established in 2015.

DSM holds a 35% stake in the joint venture, which consists of three business units: Aliancys, AnQore, and Fibrant.

DSM has been applying IFRS 11 to its associates and joint ventures since 2013.

Here is a list of DSM's partnerships:

  • 2009: DSM and NCPC sign contracts to establish nutrition and anti-infectives joint ventures in China
  • 2011: DSM Sinochem Pharmaceuticals, joint venture (DSM 50%) with the Sinochem Group
  • 2015: ChemicaInvest, joint venture (DSM 35%) with CVC Capital Partners

Funding and Investors

Credit: youtube.com, How To Find Angel Investors (5 ways to reach them)

DSM has raised funding over 26 rounds, starting with its first round on April 30, 2009.

Its latest funding round was a Grant (prize money) round on July 31, 2023, securing $2.12M in funding.

Only one investor participated in its latest round, which included notable investors like Bain Capital, Aimforthemoon, Triodos Investment Management, and JAFCO Asia.

DSM has a total of 10 institutional investors, with Bain Capital, Aimforthemoon, and Triodos Investment Management being some of the key players.

Recommended read: Triodos Bank

Competitive Landscape

DSM has some notable competitors in the market. Cult.fit, for instance, has secured a total funding of $667 million, with investors like Accel and Chiratae Ventures on board.

Cult.fit is a provider of fitness memberships, encompassing group classes, gyms, and at-home workouts. This is quite different from DSM's focus on health, nutrition, and bioscience.

Here's a snapshot of the top 5 competitors in the market, ranked by their Tracxn score:

DSM's Tracxn score of 53/100 suggests that while it's a significant player in the market, it has some catching up to do in terms of innovation and market presence.

Shareholder Information

Credit: youtube.com, DSM-Firmenich is a smarter, faster working engine post merger, says CEO

As a shareholder of DSM, you'll want to know how to stay informed about the company's performance and upcoming events.

DSM is a global purpose-led company that operates in a few different segments, including Nutrition, Health and Performance Materials, and Polymers.

The company's shares are listed on the Euronext Amsterdam stock exchange under the ticker symbol DSM.

You can find information about DSM's financial reports and investor presentations on their website.

The company's annual reports provide a detailed overview of DSM's performance, including financial results, operational highlights, and strategic updates.

Shareholders can also register for email updates to receive notifications about upcoming events, such as earnings releases and investor meetings.

The DSM website has a dedicated investor relations section where you can find all the information you need as a shareholder.

As a shareholder, you have the right to attend DSM's annual general meeting, where you can meet the management team and other shareholders.

Sustainability and Governance

Credit: youtube.com, DSM: Pioneers of a Sustainable World

DSM has a strong track record of sustainability, having been the Materials industry group leader in the Dow Jones Sustainability Index for 7 years since 2004.

This leadership position is a testament to the company's commitment to environmentally responsible practices and its efforts to minimize its impact on the environment.

Since 2004, DSM has been consistently ranked among the leaders in the annual Dow Jones Sustainability Index, demonstrating its ongoing dedication to sustainability.

For another approach, see: Djsi Dow Jones Sustainability Index

Sustainability

DSM has been a leader in sustainability since 2004, either as the Materials industry group leader or among the leaders in the annual Dow Jones Sustainability Index.

They've held this position for 7 years, demonstrating their commitment to environmentally friendly practices.

Being among the leaders in the Dow Jones Sustainability Index is no small feat, indicating that DSM is doing something right when it comes to sustainability.

DSM's dedication to sustainability has been recognized annually since 2004.

Credit: youtube.com, Mastering data and tech: The pre-requisites to sustainability compliance & transformation

DSM, a company known for its commitment to sustainability and governance, has a presence in various countries through its legal entities. DSM SINGAPORE INDUSTRIAL PTE LTD was incorporated in Singapore on July 29, 2011.

Here are some key facts about DSM's legal entities:

DSM has a significant presence in Denmark, where DSM Nutritional Products Denmark ApS was incorporated on February 11, 2020.

Frequently Asked Questions

Is DSM a good company to work for?

Based on 2,095 anonymous reviews, DSM-Firmenich has a 3.8/5 rating, with 79% of employees recommending it to a friend, indicating a generally positive work environment. However, a 1% decrease in rating over 12 months suggests some room for improvement.

Is dsm-firmenich a big company?

Yes, dsm-firmenich is a large company, formed by the combination of a global leader in health and bioscience with the world's largest privately-owned fragrance and taste company. This merger brings together two industry giants, creating a significant player in the market.

Teri Little

Writer

Teri Little is a seasoned writer with a passion for delivering insightful and engaging content to readers worldwide. With a keen eye for detail and a knack for storytelling, Teri has established herself as a trusted voice in the realm of financial markets news. Her articles have been featured in various publications, offering readers a unique perspective on market trends, economic analysis, and industry insights.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.